HSA
COLL icon

Hussman Strategic Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Hussman Strategic Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-105,000
Closed -$3.47M – 249
2026
Q1 		$3.47M Buy
+105,000
New +$4.45M 0.75% 16
2025
Q1 		– Sell
-31,500
Closed -$902K – 256
2024
Q4 		$902K Sell
31,500
-10,500
-25% -$347K 0.27% 146
2024
Q3 		$1.62M Buy
+42,000
New +$1.5M 0.4% 115
2020
Q4 		– Sell
-102,000
Closed -$2.12M – 282
2020
Q3 		$2.12M Buy
+102,000
New +$1.84M 0.56% 57

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Hussman Strategic Advisors's COLL Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 105,000 shares — an estimated $3.47M sold.

Hussman Strategic Advisors first reported a position in COLL in Q3 2020 and held it in 4 quarters. The position peaked at $3.47M in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Hussman Strategic Advisors reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 105,000 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.47M.
  • Hussman Strategic Advisors first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 4 quarters.
  • Hussman Strategic Advisors's Collegium Pharmaceutical position peaked at $3.47M in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.